Skip to content
Recombinetics logo — Delivering the Next Evolution of Healthcare

Recombinetics

Delivering the Next Evolution of Healthcare

Founded 2008 United States Eagan, United States 17 employees Series A Total: $65.86M Biotechnology, Health Care +1

General Information

Company Name Recombinetics
Founded Year 2008
Location United States Eagan, United States
Founders / Decision Makers
Team member
Employees 17
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Recombinetics. To contact Recombinetics, visit recombinetics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Recombinetics compare?

A PDF of Recombinetics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Recombinetics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Recombinetics

Recombinetics, founded in 2008, is a global leader in proprietary gene repair and gene-editing technology. The company's breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in regenerative medicine, disease research, and animal agriculture. Led by a team of expert geneticists, genome engineers, and reproductive physiologists, the company is headquartered in St. Paul, Minnesota. Recombinetics operates in the biotechnology, healthcare, and life sciences industries. The company recently secured a Series A investment on 21 August 2018. The details of the investors involved in this funding round were not disclosed. Recombinetics' focus on gene editing technologies places it at the forefront of the evolving healthcare landscape, with potential applications across various sectors including medicine, research, and agriculture.

Business keywords: gene editing, regenerative medicine, disease research, animal agriculture, biomedical research, livestock productivity, precision breeding, pre-clinical research, genetic engineering, genome editing, aquaculture, geneticists, genome engineers, reproductive physiologists, biomedicine

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $34.00M -
21 Aug 2018
Venture Round $4.22M -
08 Mar 2018
Funding Round $701.78K -
11 Jan 2018
Venture Round $82.50K -
02 Oct 2017
Debt Financing $6.98M -
27 Apr 2017
Venture Round $11.00M -
14 Nov 2016
Venture Round $630.00K -
23 Aug 2016
Venture Round $5.66M -
08 Jul 2016
Venture Round $540.80K -
30 Oct 2014
Venture Round $35.00K 1
Grant Newlin
09 Aug 2013

View All 11 Funding Rounds

Recombinetics Alternatives & Competitors

View All Alternatives
Recombinetics vs

CRISPR

Series E
9 employees
Biopharma, Biotechnology
Recombinetics vs
EmendoBio
EmendoBio United States

Making any gene targetable

Corporate Round
41 employees
Biotechnology, Health Care
Recombinetics vs

Měníme klasické paradigma léčby

4 employees
Biotechnology, Health Care

FAQ About Recombinetics

Delivering the Next Evolution of Healthcare
Recombinetics was founded in 2008.
Recombinetics is headquartered in Eagan, United States.
Recombinetics operates in Biotechnology, Health Care and Life Sciences. Its work centres on gene editing, regenerative medicine, disease research and animal agriculture.
Recombinetics has approximately 17 employees.
Recombinetics has completed 11 funding rounds, raising a total of $65.86M. The latest funding stage is Series A.
Top alternatives and competitors to Recombinetics include G+FLAS Life Sciences, Inc., EmendoBio, PrimeCell Bioscience, a.s., InVivo Biosystems, Tessera Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Recombinetics and G+FLAS Life Sciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Recombinetics, https://bouncewatch.com/company/recombinetics, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout